Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Meconium aspiration syndrome (MAS) is an important cause of severe respiratory failure in
newborn infants. Treatment for MAS is mainly supportive but surfactant therapy might change
the course of the disease. Aim of the study to evaluate whether lung lavage with dilute or
bolus poractant alfa changes the duration of mechanical respiratory support or other outcomes
in MAS.
Phase:
Phase 4
Details
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital